Oncogene - Nature
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes.

Engineered extrachromosomal oncogene amplifications promote ...
These results demonstrate the generation of a targeted focal oncogene amplification mediated by replication-competent and transcriptionally active engineered ecDNAs in several primary cell types.

Methylmalonic acid induces metabolic abnormalities and exhaustion in ...
Hossein Kashfi, Min Liu, Leonardo Silvane, Dorina Avram, Juan Fernández-García, John M. Asara, Sarah-Maria Fendt, John L. Cleveland & Ana P. Gomes Oncogene 44, 105–114 (2025) Cite this article

Oncogenic gene fusions in cancer: from biology to therapy
Oncogenic fusions include aberrations that join a strong promoter that drives overexpression and a second proto-oncogene (e.g., TRABD–DDR2), 41 leading to downstream deregulation. 42, 43 ...

Browse Articles | Oncogene - Nature
LZTR1 is a melanoma oncogene that promotes invasion and suppresses apoptosis Antonella Bacchiocchi Michael Mak Ruth Halaban ArticleOpen Access30 Aug 2025 Previous page page 1 page 2 page 3 ...

Therapeutic implication of oxidative stress-induced growth ... - Nature
Moreover, OSGIN1 overexpression upregulated mRNAs of various oxidative stress genes, such as GPX2, NQO1, v-maf musculoaponeurotic oncogene homolog G (MAFG), and HMOX1.

RAC1B function is essential for breast cancer stem cell ... - Nature
Oncogene. 2000;19:3013–20. Article CAS PubMed Google Scholar Zhou C, Licciulli S, Avila JL, Cho M, Troutman S, Jiang P, et al. The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis.

Proto-oncogenes to Oncogenes to Cancer | Learn Science at Scitable - Nature
Mutations in proto-oncogenes are typically dominant in nature, and the mutated version of a proto-oncogene is called an oncogene.

Transcriptional regulation by MYC: an emerging new model | Oncogene
The MYC oncogene — the grand orchestrator of cancer growth and immune evasion Article 10 September 2021

Iron addiction: a novel therapeutic target in ovarian cancer - Oncogene
Although SV40T is not a human oncogene, its validity as an experimental tool in the study of ovarian cancer has been shown by studies demonstrating that its effects can be mimicked by disabling ...